|
|
(47 intermediate revisions by 13 users not shown) |
label / nl | label / nl |
| | Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. |
description / fr | description / fr |
| article scientifique | | article scientifique publié en 2010 |
description / pt | description / pt |
| artigo científico | | artigo científico (publicado na 2010) |
description / da | description / da |
| videnskabelig artikel | | videnskabelig artikel (udgivet 2010) |
description / uk | description / uk |
| | наукова стаття, опублікована у вересні 2010 |
description / ast | description / ast |
| | artículu científicu espublizáu en 2010 |
description / bg | description / bg |
| | научна статия |
description / bn | description / bn |
| | ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ |
description / el | description / el |
| | επιστημονικό άρθρο |
description / eo | description / eo |
| | scienca artikolo |
description / es | description / es |
| | artículo científico publicado en 2010 |
description / et | description / et |
| | teaduslik artikkel |
description / fa | description / fa |
| | مقالهٔ علمی |
description / fi | description / fi |
| | tieteellinen artikkeli |
description / gl | description / gl |
| | artigo científico |
description / he | description / he |
| | מאמר מדעי |
description / hu | description / hu |
| | tudományos cikk |
description / hy | description / hy |
| | գիտական հոդված |
description / ja | description / ja |
| | 2010年の論文 |
description / ka | description / ka |
| | სამეცნიერო სტატია |
description / ko | description / ko |
| | 2010년 논문 |
description / lt | description / lt |
| | mokslinis straipsnis |
description / nan | description / nan |
| | 2010 nî lūn-bûn |
description / nb | description / nb |
| | vitenskapelig artikkel |
description / nn | description / nn |
| | vitskapeleg artikkel |
description / oc | description / oc |
| | article scientific |
description / pl | description / pl |
| | artykuł naukowy |
description / pt-br | description / pt-br |
| | artigo científico (publicado na 2010) |
description / ro | description / ro |
| | articol științific |
description / ru | description / ru |
| | научная статья |
description / sq | description / sq |
| | artikull shkencor |
description / sr-ec | description / sr-ec |
| | научни чланак |
description / sr-el | description / sr-el |
| | naučni članak |
description / tg | description / tg |
| | мақолаи илмӣ |
description / tg-cyrl | description / tg-cyrl |
| | мақолаи илмӣ |
description / th | description / th |
| | บทความทางวิทยาศาสตร์ |
description / tl | description / tl |
| | artikulong pang-agham |
description / ur | description / ur |
| | سائنسی مضمون |
description / vi | description / vi |
| | bài báo khoa học |
description / wuu | description / wuu |
| | 2010年学术文章 |
description / yue | description / yue |
| | 2010年學術文章 |
description / zh | description / zh |
| | 2010年學術文章 |
description / zh-cn | description / zh-cn |
| | 2010年学术文章 |
description / zh-hans | description / zh-hans |
| | 2010年学术文章 |
description / zh-hant | description / zh-hant |
| | 2010年學術文章 |
description / zh-hk | description / zh-hk |
| | 2010年學術文章 |
description / zh-mo | description / zh-mo |
| | 2010年學術文章 |
description / zh-my | description / zh-my |
| | 2010年学术文章 |
description / zh-sg | description / zh-sg |
| | 2010年学术文章 |
description / zh-tw | description / zh-tw |
| | 2010年學術文章 |
| Property / PMC publication ID: 2946577 / reference |
| | |
Property / PMC publication ID: 2946577 / reference | |
| | |
Property / title | |
| Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. (English)
| |
Property / title: Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. (English) / rank | |
| Normal rank
| |
Property / title: Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. (English) / reference | |
| | |
| Property / instance of: scholarly article / reference |
| | |
Property / instance of: scholarly article / reference | |
| | |
| Property / author name string: Mingli Xu / reference |
| | |
Property / author name string: Mingli Xu / reference | |
| | |
| Property / author name string: Izuru Mizoguchi / reference |
| | |
Property / author name string: Izuru Mizoguchi / reference | |
| | |
| Property / author name string: Noriko Morishima / reference |
| | |
Property / author name string: Noriko Morishima / reference | |
| | |
Property / author name string | |
| Yukino Chiba
| |
Property / author name string: Yukino Chiba / rank | |
| Normal rank
| |
Property / author name string: Yukino Chiba / qualifier | |
| | |
Property / author name string: Yukino Chiba / reference | |
| | |
| Property / author name string: Junichiro Mizuguchi / reference |
| | |
Property / author name string: Junichiro Mizuguchi / reference | |
| | |
Property / author name string | |
| Takayuki Yoshimoto
| |
Property / author name string: Takayuki Yoshimoto / rank | |
| Normal rank
| |
Property / author name string: Takayuki Yoshimoto / qualifier | |
| | |
Property / author name string: Takayuki Yoshimoto / reference | |
| | |
| Property / published in: Clinical and Developmental Immunology / reference |
| | |
| Property / published in: Clinical and Developmental Immunology / reference |
| | |
| Property / published in: Clinical and Developmental Immunology / reference |
| | |
| Property / published in: Clinical and Developmental Immunology / reference |
| | |
| Property / published in: Clinical and Developmental Immunology / reference |
| | |
Property / published in: Clinical and Developmental Immunology / reference | |
| | |
| Property / volume: 2010 / reference |
| | |
Property / volume: 2010 / reference | |
| | |
| Property / DOI: 10.1155/2010/832454 / reference |
| | |
Property / DOI: 10.1155/2010/832454 / reference | |
| | |
| Property / PubMed publication ID: 20885915 / reference |
| | |
Property / PubMed publication ID: 20885915 / reference | |
| | |
| Property / page(s): 4779-4788 / reference |
| | |
Property / page(s): 4779-4788 / reference | |
| | |
| Property / publication date: 14 September 2010 / reference |
| | |
| Property / publication date: 14 September 2010 / reference |
| | |
| Property / publication date: 14 September 2010 / reference |
| | |
| Property / publication date: 14 September 2010 / reference |
| | |
| Property / publication date: 14 September 2010 / reference |
| | |
Property / publication date: 14 September 2010 / reference | |
| | |
| Property / instance of |
| | |
| Property / instance of: review article / rank |
| | Normal rank |
| Property / instance of: review article / reference |
| | stated in: PubMed retrieved: 8 February 2021Timestamp | +2021-02-08T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / cites work |
| | |
| Property / cites work: A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes / rank |
| | Normal rank |
| Property / cites work: A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow / rank |
| | Normal rank |
| Property / cites work: Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment / rank |
| | Normal rank |
| Property / cites work: Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-35: odd one out or part of the family? / rank |
| | Normal rank |
| Property / cites work: Interleukin-35: odd one out or part of the family? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation / rank |
| | Normal rank |
| Property / cites work: New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The inhibitory cytokine IL-35 contributes to regulatory T-cell function / rank |
| | Normal rank |
| Property / cites work: The inhibitory cytokine IL-35 contributes to regulatory T-cell function / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway / rank |
| | Normal rank |
| Property / cites work: Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice / rank |
| | Normal rank |
| Property / cites work: Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis / rank |
| | Normal rank |
| Property / cites work: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. / rank |
| | Normal rank |
| Property / cites work: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells / rank |
| | Normal rank |
| Property / cites work: Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Regulatory T cells in cancer / rank |
| | Normal rank |
| Property / cites work: Regulatory T cells in cancer / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-23 promotes tumour incidence and growth / rank |
| | Normal rank |
| Property / cites work: IL-23 promotes tumour incidence and growth / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells / rank |
| | Normal rank |
| Property / cites work: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Transforming growth factor-beta induces development of the T(H)17 lineage / rank |
| | Normal rank |
| Property / cites work: Transforming growth factor-beta induces development of the T(H)17 lineage / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Regulatory T cells, tumour immunity and immunotherapy / rank |
| | Normal rank |
| Property / cites work: Regulatory T cells, tumour immunity and immunotherapy / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: GM-CSF gene-transduced tumor vaccines / rank |
| | Normal rank |
| Property / cites work: GM-CSF gene-transduced tumor vaccines / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. / rank |
| | Normal rank |
| Property / cites work: Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The STATs of cancer--new molecular targets come of age / rank |
| | Normal rank |
| Property / cites work: The STATs of cancer--new molecular targets come of age / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses / rank |
| | Normal rank |
| Property / cites work: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Antitumor and antimetastatic activity of IL-23 / rank |
| | Normal rank |
| Property / cites work: Antitumor and antimetastatic activity of IL-23 / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment / rank |
| | Normal rank |
| Property / cites work: Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain / rank |
| | Normal rank |
| Property / cites work: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. / rank |
| | Normal rank |
| Property / cites work: Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 / rank |
| | Normal rank |
| Property / cites work: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells / rank |
| | Normal rank |
| Property / cites work: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-12 in anti-tumor immunity and immunotherapy. / rank |
| | Normal rank |
| Property / cites work: Interleukin-12 in anti-tumor immunity and immunotherapy. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy / rank |
| | Normal rank |
| Property / cites work: IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Inflammation and cancer: back to Virchow? / rank |
| | Normal rank |
| Property / cites work: Inflammation and cancer: back to Virchow? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 / rank |
| | Normal rank |
| Property / cites work: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The toxicology of interleukin-12: a review / rank |
| | Normal rank |
| Property / cites work: The toxicology of interleukin-12: a review / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses / rank |
| | Normal rank |
| Property / cites work: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity / rank |
| | Normal rank |
| Property / cites work: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy / rank |
| | Normal rank |
| Property / cites work: Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity / rank |
| | Normal rank |
| Property / cites work: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes / rank |
| | Normal rank |
| Property / cites work: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells / rank |
| | Normal rank |
| Property / cites work: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells / rank |
| | Normal rank |
| Property / cites work: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities / rank |
| | Normal rank |
| Property / cites work: IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Antiproliferative activity of IL-27 on melanoma / rank |
| | Normal rank |
| Property / cites work: Antiproliferative activity of IL-27 on melanoma / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. / rank |
| | Normal rank |
| Property / cites work: Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. / rank |
| | Normal rank |
| Property / cites work: Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Antiangiogenic and antitumor activities of IL-27. / rank |
| | Normal rank |
| Property / cites work: Antiangiogenic and antitumor activities of IL-27. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: A role for IL-27 in early regulation of Th1 differentiation / rank |
| | Normal rank |
| Property / cites work: A role for IL-27 in early regulation of Th1 differentiation / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. / rank |
| | Normal rank |
| Property / cites work: Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. / rank |
| | Normal rank |
| Property / cites work: Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. / rank |
| | Normal rank |
| Property / cites work: Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells / rank |
| | Normal rank |
| Property / cites work: IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells / rank |
| | Normal rank |
| Property / cites work: An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Antitumor and antimetastatic activity of interleukin 12 against murine tumors / rank |
| | Normal rank |
| Property / cites work: Antitumor and antimetastatic activity of interleukin 12 against murine tumors / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Role of interferon-gamma in interleukin 12-induced pathology in mice. / rank |
| | Normal rank |
| Property / cites work: Role of interferon-gamma in interleukin 12-induced pathology in mice. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma / rank |
| | Normal rank |
| Property / cites work: Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. / rank |
| | Normal rank |
| Property / cites work: Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. / rank |
| | Normal rank |
| Property / cites work: Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. / rank |
| | Normal rank |
| Property / cites work: A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Swords into plowshares: IL-23 repurposes tumor immune surveillance / rank |
| | Normal rank |
| Property / cites work: Swords into plowshares: IL-23 repurposes tumor immune surveillance / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Potent antitumor activity of interleukin-27. / rank |
| | Normal rank |
| Property / cites work: Potent antitumor activity of interleukin-27. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production / rank |
| | Normal rank |
| Property / cites work: WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection / rank |
| | Normal rank |
| Property / cites work: The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells / rank |
| | Normal rank |
| Property / cites work: Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients / rank |
| | Normal rank |
| Property / cites work: Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 / rank |
| | Normal rank |
| Property / cites work: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin-12: role of interferon-gamma in IL-12 adverse effects / rank |
| | Normal rank |
| Property / cites work: Interleukin-12: role of interferon-gamma in IL-12 adverse effects / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression / rank |
| | Normal rank |
| Property / cites work: Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial / rank |
| | Normal rank |
| Property / cites work: Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system / rank |
| | Normal rank |
| Property / cites work: Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity / rank |
| | Normal rank |
| Property / cites work: The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Sciencescope / rank |
| | Normal rank |
| Property / cites work: Sciencescope / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells / rank |
| | Normal rank |
| Property / cites work: Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation / rank |
| | Normal rank |
| Property / cites work: IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: IL-27-mediated activation of natural killer cells and inflammation produced antitumour effects for human oesophageal carcinoma cells / rank |
| | Normal rank |
| Property / cites work: IL-27-mediated activation of natural killer cells and inflammation produced antitumour effects for human oesophageal carcinoma cells / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone / rank |
| | Normal rank |
| Property / cites work: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells / rank |
| | Normal rank |
| Property / cites work: Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells / reference |
| | |
| Property / ResearchGate publication ID |
| | |
| Property / ResearchGate publication ID: 47157547 / rank |
| | Normal rank |
| Property / copyright license |
| | |
| Property / copyright license: Creative Commons Attribution 3.0 Unported / rank |
| | Normal rank |
| Property / copyright license: Creative Commons Attribution 3.0 Unported / reference |
| | |
| Property / copyright license: Creative Commons Attribution 3.0 Unported / reference |
| | |
| Property / copyright license: Creative Commons Attribution 3.0 Unported / reference |
| | |
| Property / copyright license: Creative Commons Attribution 3.0 Unported / reference |
| | |
| Property / main subject |
| | |
| Property / main subject: antigen-presenting cell / rank |
| | Normal rank |
| Property / main subject: antigen-presenting cell / reference |
| | stated in: PubMed retrieved: 18 October 2019Timestamp | +2019-10-18T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / main subject |
| | |
| Property / main subject: interleukin 12 / rank |
| | Normal rank |
| Property / main subject: interleukin 12 / reference |
| | stated in: PubMed retrieved: 20 November 2019Timestamp | +2019-11-20T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / main subject |
| | |
| Property / main subject: neoplasm / rank |
| | Normal rank |
| Property / main subject: neoplasm / reference |
| | stated in: PubMed retrieved: 8 February 2021Timestamp | +2021-02-08T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / on focus list of Wikimedia project |
| | |
| Property / on focus list of Wikimedia project: ScienceSource / rank |
| | Normal rank |
| Property / title |
| | Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27 (English) |
| Property / title: Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27 (English) / rank |
| | Normal rank |
| Property / title: Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27 (English) / reference |
| | |
| Property / author |
| | |
| Property / author: Yukino Chiba / rank |
| | Normal rank |
| Property / author: Yukino Chiba / qualifier |
| | |
| Property / author: Yukino Chiba / reference |
| | |
| Property / author |
| | |
| Property / author: Takayuki Yoshimoto / rank |
| | Normal rank |
| Property / author: Takayuki Yoshimoto / qualifier |
| | |
| Property / author: Takayuki Yoshimoto / reference |
| | |
| Property / copyright status |
| | |
| Property / copyright status: copyrighted / rank |
| | Normal rank |
| Property / language of work or name |
| | |
| Property / language of work or name: English / rank |
| | Normal rank |
| Property / language of work or name: English / reference |
| | |